| 國立成功大學 |
2023-05 |
Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non-Small Cell Lung Cancer in Taiwan
|
Chang;Wei-Ting;Lin;Hui-Wen;Chang;Ting-Chia;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2023-04-28 |
Impact of infection-related admission in patients with heart failure: a 10 years national cohort study
|
Chen;Chao-Yu;Lee;Cheng-Han;Lin;Hui-Wen;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2023-04-17 |
The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan
|
Chang;Wei-Ting;Lin;Hui-Wen;Chang;Ting-Chia;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2023-04 |
Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia
|
Chang;Wei-Ting;Lin;Hui-Wen;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2022-12-15 |
Soluble tumor endothelial marker 1 in heart failure with reduced ejection fraction: A pilot study
|
Feng;Wen-Han;Chen;Po-Sheng;Chung;Hsing-Chun;Lin;Yi-Hsiung;Li;Yi-Heng |
| 國立成功大學 |
2022-12 |
Effects of Cilostazol on Angiogenesis in Diabetes through Adiponectin/Adiponectin Receptors/Sirtuin1 Signaling Pathway
|
Tseng;Shih-Ya;Chang;Hsien-Yuan;Li;Yi-Heng;Chao;Ting-Hsing |
| 國立成功大學 |
2022-12 |
2022 Taiwan lipid guidelines for primary prevention
|
Huang;Po-Hsun;Lu;Ya-Wen;Tsai;Yi-Lin;Wu;Yen-Wen;Li;Hung-Yuan;Chang;Hsin-Yun;Wu;Chih-Hsing;Yang;Chih-Yu;Tarng;Der-Cherng;Huang;Chin-Chou;Ho;Li-Ting;Lin;Chao-Feng;Chien;Shih-Chieh;Wu;Yih-Jer;Yeh;Hung-I;Pan;Wen-Harn;Li;Yi-Heng |
| 國立成功大學 |
2022-08 |
2022 focused update of the 2017 Taiwan lipid guidelines for high risk patients: Coronary artery disease, peripheral artery disease and ischemic stroke
|
Chen;Po-Sheng;Lee;Meng;Tang;Sung-Chun;Huang;Po-Hsun;Yeh;Hung-;I;Hou;Charles, Jia-Yin;Hsieh;I-Chang;Lee;Jiunn-Tay;Jeng;Jiann-Shing;Li;Yi-Heng |
| 國立成功大學 |
2022-06-22 |
Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling
|
Chen;Po-Sheng;Feng;Wen-Han;Tsai;Tzu-Hsien;Hong;Yi-Kai;Lee;An-Sheng;Chang;Kuan-Cheng;Chung;Hsing-Chun;Liu;Yen-Wen;Hsieh;Chih-Cheng;Fang;Yi-Hsian;Yang;Pei-Jung;Luo;Chawn-Yau;Liu;Ping-Yen;Cheng;Tsung-Lin;Li;Yi-Heng |
| 國立成功大學 |
2022-02-24 |
Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy
|
Huang;Sheng-Wei;Chen;Po-Wei;Feng;Wen-Han;Hsieh;I-Chang;Ho;Ming-Yun;Cheng;Chung-Wei;Yeh;Hung-;I;Chen;Ching-Pei;Huang;Wei-Chun;Fang;Ching-Chang;Lin;Hui-Wen;Lin;Sheng-Hsiang;Tsai;Chin-Feng;Su;Chun-Hung;Li;Yi-Heng |
| 國立成功大學 |
2022-02 |
Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia
|
Chang;Wei-Ting;Chen;Po-Wei;Lin;Hui-Wen;Kuo;Yu-Hsuan;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2022 |
Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study
|
Lin;Jia-Ling;Chen;Po-Sheng;Lin;-Wen, Hui;Tsai;Liang-Miin;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2021-11 |
Endovascular Therapy for Venous Thromboembolic Diseases
|
Su;Yi-Jia;Chang;Hsien-Yuan;Li;Yi-Heng |
| 國立成功大學 |
2021-09-24 |
Genetic risk model for in-stent restenosis of second- and third-generation drug-eluting stents
|
Liu;Yen-Wen;Huang;Mu-Shiang;Hsu;Ling-Wei;Chang;Hsien-Yuan;Lee;Cheng-Han;Lee;Chi-Ying;Chen;Dao-Peng;Li;Yi-Heng;Chao;Ting-Hsin;Su;Pei-Fang;Shen;Meng-Ru;Liu;Ping-Yen |
| 國立成功大學 |
2021-07 |
Addressing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following COVID-19 Vaccination: A Mini-Review of Practical Strategies
|
Chen;Po-Wei;Tsai;Zong-Yun;Chao;Ting-Hsing;Li;Yi-Heng;Hou;Charles, Jia-Yin;Liu;Ping-Yen |
| 國立成功大學 |
2021-05-12 |
Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy
|
Ho;Ming-Yun;Chen;Po-Wei;Feng;Wen-Han;Su;Chun-Hung;Huang;Sheng-Wei;Cheng;Chung-Wei;Yeh;Hung-I;Chen;Ching-Pei;Huang;Wei-Chun;Fang;Ching-Chang;Lin;Hui-Wen;Lin;Sheng-Hsiang;Hsieh;I-Chang;Li;Yi-Heng |
| 國立成功大學 |
2021-03 |
Risk of infectious events in acute myocardial infarction patients treated with ticagrelor or clopidogrel
|
Lee;Cheng-Han;Lin;Hui-Wen;Lee;Nan-Yao;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2021-03 |
Reduced-Dose Prasugrel versus Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention A Meta-Analysis of Randomized and Observational Studies
|
Lee;Cheng-Han;Huang;Mu-Shiang;Chao;Ting-Hsing;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2021-01 |
P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: Is It Safe to Abandon Aspirin?
|
Feng;Wen-Han;Hsieh;I-Chang;Li;Yi-Heng |
| 國立成功大學 |
2020-12 |
Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus
|
Chen;Ju-Yi;Lee;Shuenn-Yuh;Li;Yi-Heng;Lin;Chia-Yu;Shieh;Meng-Dar;Ciou;Ding-Siang |
| 國立成功大學 |
2020-10 |
Calcified abdominal cocoons
|
Chen;Ju-Yi;Li;Yi-Heng |
| 國立成功大學 |
2020-09 |
Appropriate Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Atherosclerotic Cardiovascular Disease: Comparison of Recommendations from Different Guidelines or Consensus Around the World
|
Lin;Jia-Ling;Huang;Po-Hsun;Yeh;Hung-;I;Li;Yi-Heng |
| 國立成功大學 |
2020-06 |
P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
|
Chen;Po-Wei;Feng;Wen-Han;Ho;Ming-Yun;Su;Chun-Hung;Huang;Sheng-Wei;Cheng;Chung-Wei;Yeh;Hung-;I;Chen;Ching-Pei;Huang;Wei-Chun;Fang;Ching-Chang;Lin;Hui-Wen;Lin;Sheng-Hsiang;Hsieh;I-Chang;Li;Yi-Heng |
| 國立成功大學 |
2020-06 |
Ef ficacy and Safety of High -intensity Statins in Patients With Acute Myocardial Infarction: An Asian Perspective
|
Chen;Po-Sheng;Lin;Sheng-Hsiang;Lee;Cheng-Han;Lin;Hui-Wen;Li;Yi-Heng |
| 國立成功大學 |
2020-02 |
Changing Treatment Patterns in Patients With Venous Thromboembolism in Taiwan
|
Lee;Cheng-Han;Fang;Ching-Chang;Tsai;Liang-Miin;Lin;Hui-Wen;Chen;Po-Sheng;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2019-10 |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
Chien;Shih-Chieh;Chen;Po-Sheng;Huang;Yi-Hsiang;Tang;Sung-Chun;Li;Yi-Heng;Yeh;Hung-;I |
| 國立成功大學 |
2019-08 |
The role of vascular smooth muscle cell membrane-bound thrombomodulin in neointima formation
|
Wang;Kuan-Chieh;Chen;Po-Sheng;Chao;Ting-Hsing;Luo;Chawn-Yau;Chung;Hsing-Chun;Tseng;Shih-Ya;Huang;Ting-Yu;Lin;Ying-Li;Shi;Guey-Yueh;Wu;Hua-Lin;Li;Yi-Heng |
| 國立成功大學 |
2019-06 |
The role of N-terminal pro-B-type natriuretic peptide in prognostic evaluation of heart failure
|
Lam;Carolyn, S. P.;Li;Yi-Heng;Bayes-Genis;Antoni;Ariyachaipanich;Aekarach;Huan, Do Quang;Sato;Naoki;Kahale;Pravin;Cuong, Ta Manh;Dong;Yugang;Li;Xinli;Zhou;Yanli |
| 國立成功大學 |
2019-03 |
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan
|
Fang;Chen-Wen;Tsai;Yi-Te;Chou;Ping-Chen;Chen;Hsi-Ming;Lu;Chien-Ming;Tsao;Chen-Rong;Chen;Chih-Lin;Sun;Mu-Chien;Shih;Yu-Song;Hsieh;Cheng-Yang;Chen;Lu-An;Chen;Po-Lin;Yeh;Jung-Tze;Li;Yi-Heng |
| 國立成功大學 |
2018-12-15 |
Patterns of Acute Myocardial Infarction in Taiwan from 2009 to 2015
|
Lee;Cheng-Han;Fang;Ching-Chang;Tsai;Liang-Miin;Gan;Shu-Ting;Lin;Sheng-Hsiang;Li;Yi-Heng |
| 國立成功大學 |
2018-10 |
Comparison of the 2017 Taiwan lipid guidelines and the Western lipid guidelines for high risk patients
|
Li;Yi-Heng;Yeh;Hung-I;Jeng;Jiann-Shing;Charng;Min-Ji |
| 國立成功大學 |
2018-09 |
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients
|
Li;Yi-Heng;Chao;Ting-Hsing;Liu;-Yen, Ping;Ueng;Kwo-Chang;Yeh;Hung-I |
| 國立成功大學 |
2018-03-20 |
The Taiwan Heart Registries Its Influence on Cardiovascular Patient Care
|
Wu;Cho-Kai;Juang;Jimmy, Jyh-Ming;Chiang;Jiun-Yang;Li;Yi-Heng;Tsai;Chia-Ti;Chiang;Fu-Tien |
| 國立成功大學 |
2018-03 |
Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan
|
Lee;Cheng-Han;Cheng;Ching-Lan;Yang;Kao, Yea-Huei;Chao;Ting-Hsing;Chen;Ju-Yi;Li;Yi-Heng |
| 國立成功大學 |
2018-02 |
Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan
|
Tsai;Li-Kai;Lin;Huey-Juan;Chua;Su-Kiat;Liao;Pen-Chih;Yang;Yuan-Po;Chou;Ping-Chen;Lee;Chun-Wei;Lin;Mao-Jen;Chen;Hsi-Ming;Yeh;Jung-Tze;Li;Yi-Heng |
| 國立成功大學 |
2017-09 |
Recovery of gold from industrial wastewater by extracellular proteins obtained from a thermophilic bacterium Tepidimonas fonticaldi AT-A2
|
Han;Yin-Lung;Wu;Jen-Hao;Cheng;Chieh-Lun;Nagarajan;Dillirani;Lee;Ching-Ray;Li;Yi-Heng;Lo;Yung-Chung;Chang;Jo-Shu |
| 國立成功大學 |
2017-06-12 |
Recombinant Thrombomodulin Exerts Anti-autophagic Action in Endothelial Cells and Provides Anti-atherosclerosis Effect in Apolipoprotein E Deficient Mice
|
Chen;Po-Sheng;Wang;Kuan-Chieh;Chao;Ting-Hsing;Chung;Hsing-Chun;Tseng;Shi-Ya;Luo;Chawn-Yau;Shi;Guey-Yueh;Wu;Hua-Lin;Li;Yi-Heng |
| 國立成功大學 |
2017-05 |
Life cycle assessment of palm-derived biodiesel in Taiwan
|
Maharjan;Sumit;Wang;Wei-Cheng;Teah;Yi, Heng |
| 國立成功大學 |
2017-03 |
Ticagrelor safety profile in real-life setting of acute coronary syndrome patients Reply
|
Chen;I-Chih;Lee;Cheng-Han;Li;Yi-Heng;Chao;Ting-Hsing |
| 國立成功大學 |
2017-01-15 |
Calcium ion adsorption with extracellular proteins of thermophilic bacteria isolated from geothermal sites-A feasibility study
|
Han;Ying-Lung;Lo;Yung-Chung;Cheng;Chieh-Lun;Yu;Wan-Ju;Nagarajan;Dillirani;Liu;Chih-Hsi;Li;Yi-Heng;Chang;Jo-Shu |
